Premium
Treatment of pemphigus with cyclophosphamide
Author(s) -
PASRICHA J.S.,
SOOD V.D.,
MINOCHA Y.
Publication year - 1975
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1975.tb02251.x
Subject(s) - cyclophosphamide , pemphigus , medicine , dermatology , chemotherapy , gastroenterology
SUMMARY Cyclophosphamide was ineffective in controlling acute disease activity in nine of eleven pemphigus patients, but when given during the remission phase even 50 mg cyclophosphamide per day was sufficient to prevent subsequent relapses in all the patients for quite long periods of follow‐up. This small dose of cyclophosphamide could be given to outpatients and there were no side effects.